|
February 28, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 1:09 FDA Clears innovative treatment for obstructive sleep disorders https://www.prnewswire.com/news-releases/fda-clears-innovative-treatment-for-obstructive-sleep-disorders-300605470.html 3:26 Acclarent Receives FDA Clearance For Expanded Indication Of Acclarent AERA® Eustachian Tube Balloon Dilation System https://www.prnewswire.com/news-releases/acclarent-receives-fda-clearance-for-expanded-indication-of-acclarent-aera-eustachian-tube-balloon-dilation-system-300604432.html 5:43 Brain Implant for Some Blind People Shows Benefits of FDA’s Breakthrough Device Program | FDA Voice https://blogs.fda.gov/fdavoice/index.php/2018/02/brain-implant-for-some-blind-people-shows-benefits-of-fdas-breakthrough-device-program/ Please check out my weekly podcast AI in Medicine. In this week’s episode I talk to Kevin Harris, CEO of Curemetrix. He describes how their technology called CMAssist may be able to find cancer earlier; they were able to look 6 years earlier and find anomalies that were missed by doctors and eventually grew into cancers. They are in the process of getting FDA approval but doctors can currently test it out for investigational uses prospectively and can also provide retrospective data for analysis. Podcast website is http://aimedicinenews.com Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/ |